List of 'Reasons Not to Eat Your Food if You're a Cat' Has People in Stitches
Everyone has different tastes when it comes to food. From preferring certain flavors to having serious thoughts on ideal temperatures and even favorite cookware, the variations are endless.
While humans can be fussy about their meals, cats take it to another level. In a hilarious video uploaded to TikTok, the reasons a finicky feline may refuse to eat are outlined, and the explanations are so funny because they're absolutely true! Let's see what we have here.
"Reasons not to eat your food if you're a cat," the caption states.
Ready for the list? Here we go!
Bowl was placed down too loudly.
The vibe was off.
Don't like chicken, as of today.
Felt like I was being rushed.
I'm a cat.
🐶🐾🐾
The way this kitty looks away at the end of the video really feels like a, "Yup, that about sums it up!"
List validated!And yet viewers were quick to chime in to add to the list, revealing some of their pets' peculiar "pet peeves" that may ruin an otherwise nice meal.
"Oh yes, my bowl was faced the wrong way," one wrote.
"I eat at 4:30 p.m., not 4:31 p.m.," another pointed out.
Another commented, "I want the other can, not the open one in the fridge: new can every feeding 😡😉."
Kitties, take note, it seems like your family members are on to you!Anyone who's loved and cared for a feline knows their tastes can change hourly. So why is that?
According to PetMD, their fussiness may have something to do with their natural instincts, as their ancestors were hunters who grazed on different small meals throughout the day. They may also like their food placed in certain locations. Dishes beside the litter box get a hard pass.
If your cat stops eating and it seems like more than just a change in preference, it could be a health issue, and a visit to the vet may be in order. (Please don't tell your pet I said this!)
One of the reasons I think kitties are so persnickety is because they know they can get away with it — at least in my house!
List of 'Reasons Not to Eat Your Food if You're a Cat' Has People in Stitches first appeared on Parade Pets on Jul 5, 2025
This story was originally reported by Parade Pets on Jul 5, 2025, where it first appeared.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
Ruotong Gao Featured in XYZ Media's 'Next Generation of Innovators' for Developing a Novel Molecular Imprinted Polymer for Electrochemical Sweat Sensor
Spotlighting a 'Next Generation Innovator': Ruotong Gao's Novel Molecular Imprinted Polymer for Electrochemical Sweat Sensor LOS ANGELES, July 18, 2025 (GLOBE NEWSWIRE) -- XYZ Media, a leader in digital storytelling at the intersection of education and innovation, is proud to announce the newest feature in its 'Next Generation of Innovators' series. This digital campaign spotlights young trailblazers creating innovative solutions to global challenges. The new feature highlights Ruotong Gao for developing a wearable electrochemical sweat sensor that uses synthetic molecularly imprinted polymers (MIPs) to detect cardiovascular biomarkers in real time. Gao's sensor, capable of nanomolar detection of L-arginine, offers a non-invasive and highly selective diagnostic platform for early-stage cardiovascular disease monitoring. "I drew my inspiration from what I felt could actually improve the patient experience," Gao explained. "Our current healthcare system typically revolves around treatment post-symptoms but could benefit tremendously from early biomarker-based detection of diseases." Gao's wearable sensor relies on highly selective synthetic antibodies — MIPs — he engineered to target L-arginine, a key cardiovascular biomarker. These specialized polymers enable precise amino acid detection in sweat, offering real-time, non-invasive insights into heart health without the need for invasive blood sampling. "There were many challenges I faced within my project, but the main one was the issue of synthesizing the MIPs," said Gao. "I addressed this with heavy optimization of my procedure and many repetitions, taking around several months to get a working result." The sensor is built with tiny platinum wires coated with a special conductive material, designed to comfortably adhere to the skin. It measures electrical changes in sweat using a method called electrochemical impedance spectroscopy. Gao's sensor also achieved nanomolar-level detection of L-arginine with high selectivity—demonstrating a threefold higher impedance signal compared to structurally similar amino acids such as lysine and citrulline. In today's world where cardiovascular diseases remain one of the leading causes of death, Gao's work leads to a future of personalized, real-time healthcare, where conditions like hypertension or atherosclerosis can be detected long before symptoms appear. "My hopes are that, in the future, everyone will have access to a more personalized system for medicine, allowing for point-of-care monitoring by healthcare professionals, early detection, and in general, a better understanding of the state of our bodies," Gao added. "Ruotong Gao sets the perfect example of what we look for in a 'Next Generation Innovator,'" stated Jordan Hayes, Director of Communications at XYZ Media. "Through combining chemistry, materials science, and biomedical design, Gao is making cardiovascular disease detection more simple, less expensive, more accessible for all patients." About XYZ Media: Founded in 2018, XYZ Media bridges education and technology to spotlight the next generation of change-makers. XYZ Media is dedicated to spotlighting the achievements of tomorrow's leaders driving change. With a keen focus on educational excellence and digital innovation, XYZ Media fosters a community where young minds are encouraged to challenge the status quo and develop solutions for a better tomorrow. To learn more information on XYZ Media's 'Next Generation of Innovators' series, please contact: Jordan HayesDirector of Communicationspr@ XYZ Disclaimer: This content is provided by XYZ Media. The statements, views, and opinions expressed in this column are solely those of the content provider. The information shared in this press release is not a solicitation for investment, nor is it intended as investment, financial, or trading advice. It is strongly recommended that you conduct thorough research and consult with a professional financial advisor before making any investment or trading decisions. Please conduct your own research and invest at your own risk. A photo accompanying this announcement is available at
Yahoo
29 minutes ago
- Yahoo
Scar tissue in athletes hearts tied to higher risk of dangerous cardiac rhythms
Research Highlights: Scar tissue in the heart may be linked to dangerous heart rhythms in otherwise healthy athletes, according to a U.K. study. The study, VENTOUX, named after Mont Ventouxone of the most gruelling climbs in the world-renowned Tour de France cycling raceincluded about 100 male cyclists and triathletes over age 50. Embargoed until 6:01 p.m. CT/7:01 p.m. ET, Thursday, July 17, 2025 (NewMediaWire) - July 17, 2025 - DALLAS Scar tissue in the heart was associated with abnormal heart rhythms among healthy, long-time male endurance athletes age 50 or older, potentially increasing their risk of sudden cardiac death, according to a small study published today in Circulation:Cardiovascular Imaging, an American Heart Association journal. An irregular rhythm originating from a ventricular heart chamber, called ventricular tachycardia, is considered one of the most serious types of abnormal heart rhythm. It is extremely dangerous and can lead to sudden cardiac death. Sudden cardiac arrest is a leading cause of death in athletes, mostly affecting older men. Myocardial fibrosisthe scarring or thickening of heart muscle tissuehas previously been linked to irregular heartbeats; however, how it affects otherwise healthy endurance athletes remains unclear. "Dangerous heart rhythms during sport are thankfully rare," said senior study author Peter Swoboda, M.B.B.S., Ph.D., an associate professor of cardiology at the University of Leeds in the U.K. "In certain highly trained athletesparticularly as they get olderit is possible to identify scarred heart tissue via magnetic resonance imaging. We wanted to investigate whether dangerous heart rhythms in endurance athletes might be caused by heart scarring. "Our main aim was to help endurance athletes continue to participate safely in sports, particularly as they get older," he said. The study called VENTOUX was named after a famous mountain climb in the world-renowned Tour de France bike race. The researchers followed 106 male cyclists/triathletes aged 50 or older, who had no symptoms of heart disease. All had trained at least 10 hours a week for 15 years or more. The participants underwent cardiovascular magnetic resonance (CMR) imaging, a specialized test that uses magnetic fields to produce detailed images of the heart. They also had an ECG recorder implanted under the skin of their chest that recorded every heartbeat for two years. During an average follow-up of two years, researchers found: almost half of the athletes (47.2%) showed signs of scarring on the left ventricle of the heart; and about 3% of the athletes had sustained, potentially dangerous fast heart rate originating in the lower chambers of the heart, while 19% experienced shorter bursts of rapid heartbeats. Any participant who developed a potentially harmful rhythm was contacted urgently to assess symptoms and advised to seek independent medical attention. "We did not expect the association between scarring and dangerous rhythms to be this strong," Swoboda said. "Similar findings have been reported in patients with heart muscle disease, however, we did not expect this in healthy, performance athletes." He urged any athlete who experiences chest pain, dizziness or palpitations during activity to seek treatment and also advised, "It's important that everyone involved in sports knows CPR and how to use an automated external defibrillator." Although the annual incidence of sudden cardiac death during sports varies among studies, the annual rate of abnormal heart rhythms detected in this study were considerably higher than rates among the general population. The study has several limitations such as including a small number of very select participants. The findings may not apply to people not represented in the study: women, non-athletes or non-European cyclists. In addition, the findings could not differentiate whether the cardiac scarring itself was the cause of irregular heart rhythms or if it was a marker for a separate underlying process. Future research will examine women, the authors said. Study details, background and design: The study enrolled 106 athletes from sporting organizations in the U.K. The athletes self-reported their training history, and those with pre-existing heart conditions were excluded. Upon entry into the study, participants underwent clinical assessments, imaging and had a loop recorder implanted. The loop recorder monitored for ventricular arrhythmia for two years. A comparative group of age-matched, male, non-athletes was enrolled to undergo the same imaging. Each participant was asked to continue with their normal daily activities and sporting habits. The study was funded by the British Heart Foundation, the National Institute for Health and Care Research, Leeds Biomedical Research Centre and Leeds Clinical Research Facility. Co-authors, disclosures are listed in the manuscript. Studies published in the American Heart Association's scientific journals are peer-reviewed. The statements and conclusions in each manuscript are solely those of the study authors and do not necessarily reflect the Association's policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives more than 85% of its revenue from sources other than corporations. These sources include contributions from individuals, foundations and estates, as well as investment earnings and revenue from the sale of our educational materials. Corporations (including pharmaceutical, device manufacturers and other companies) also make donations to the Association. The Association has strict policies to prevent any donations from influencing its science content. Overall financial information is available here. Additional Resources: Available multimedia is on right column of release link After 7:01 pm ET on July 17, 2025, view the manuscript online. AHA health information: What is an Arrhythmia? AHA health information: Watch an animation of ventricular fibrillation AHA health information: Cardiac Arrest vs Heart Attack Follow AHA/ASA news on X @HeartNews Follow news from the AHA's Circulation: Cardiovascular Imaging journal @CircImaging ### About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public's health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on Facebook, X or by calling 1-800-AHA-USA1. For Media Inquiries and AHA/ASA Expert Perspective: 214-706-1173 Bridgette McNeill: For Public Inquiries: 1-800-AHA-USA1 (242-8721) and
Yahoo
37 minutes ago
- Yahoo
Bio-Techne's Quarterly Earnings Preview: What You Need to Know
Valued at a market cap of $8.1 billion, Bio-Techne Corporation (TECH) is a leading Minneapolis-based life sciences company that develops and supplies over 500,000 high-quality products, including reagents, diagnostic tools, and analytical instruments for research, bioprocessing, and clinical diagnostics. It is expected to announce its fiscal Q4 earnings on Wednesday, Aug. 6. Prior to this event, analysts project this biotechnology company to report a profit of $0.45 per share, down 8.2% from $0.49 per share in the year-ago quarter. The company has a promising trajectory of consistently beating Wall Street's bottom-line estimates in each of the last four quarters. More News from Barchart Insider Trading Alert: Here's Who Bought Nvidia and AMD Stock Before the U.S. Chip Deal with China Dear Tesla Stock Fans, Mark Your Calendars for July 23 As QuantumScape Hits New 2025 Highs, Should You Buy, Sell, or Hold QS Stock? Our exclusive Barchart Brief newsletter is your FREE midday guide to what's moving stocks, sectors, and investor sentiment - delivered right when you need the info most. Subscribe today! For the current year, analysts expect TECH to report EPS of $1.66, up 5.7% from $1.57 in fiscal 2024. Shares of TECH have declined 31.9% over the past 52 weeks, considerably trailing both the S&P 500 Index's ($SPX) 12.7% upstick, and the Health Care Select Sector SPDR Fund's (XLV) 11.8% loss over the same time frame. On May 7, TECH shares surged over 2% after reporting its Q3 results. The company reported robust earnings driven by solid demand across its core segments, particularly in cell and gene therapy tools, diagnostics, and proteomic solutions. Its revenue came in at $316.2 million, reflecting year-over-year growth, while adjusted earnings per share stood at $0.56, beating analyst estimates. Wall Street analysts are moderately optimistic about TECH's stock, with a "Moderate Buy" rating overall. Among 15 analysts covering the stock, ten recommend "Strong Buy," and five indicate 'Hold.' The mean price target for TECH is $64.92, which indicates a notable 21.8% potential upside from the current levels. On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Sign in to access your portfolio
